{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:19:36Z","timestamp":1791317976609,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3-4","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.vph.2013.07.005","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T06:30:36Z","timestamp":1374215436000},"page":"90-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Ca2+ channel inhibitor efonidipine decreases voltage-dependent K+ channel activity in rabbit coronary arterial smooth muscle cells"],"prefix":"10.1016","volume":"59","author":[{"given":"Mi-Hyeong","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn Kyoung","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Hye","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Whan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haena","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoweon","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hun","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hyun","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2013.07.005_bb0005","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1096\/fj.00-0649fje","article-title":"Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel KV1.5","volume":"15","author":"Archer","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.vph.2013.07.005_bb0010","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbrc.2005.12.135","article-title":"KChIP2b modulates the affinity and use-dependent block of Kv4.3 by nifedipine","volume":"340","author":"Bett","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vph.2013.07.005_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/biof.158","article-title":"Voltage-gated calcium channels and disease","volume":"37","author":"Cain","year":"2001","journal-title":"Biofactors"},{"key":"10.1016\/j.vph.2013.07.005_bb0020","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.1089268","article-title":"Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels","volume":"302","author":"Chen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vph.2013.07.005_bb0025","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/01.HYP.37.5.1315","article-title":"Differential expression of voltage-gated K+ channel genes in arteries from spontaneously hypertensive and Wistar\u2013Kyoto rats","volume":"37","author":"Cox","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2013.07.005_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/107424849700200410","article-title":"Mibefradil: a new selective T-channel calcium antagonist for hypertension and angina pectoris","volume":"2","author":"Frishman","year":"1997","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.vph.2013.07.005_bb0035","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/sj.bjp.0701226","article-title":"Voltage and pHdependent block of cloned N-type Ca2+ channels by amlodipine","volume":"121","author":"Furukawa","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2013.07.005_bb0040","first-page":"464","article-title":"Selectivities of dihydropyridine derivatives in blocking Ca2+ channel subtypes expressed in Xenopus oocytes","volume":"291","author":"Furukawa","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.vph.2013.07.005_bb0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yjmcc.2003.11.003","article-title":"Inhibition of ultra-rapid delayed rectifier K+ current by verapamil in human atrial myocytes","volume":"36","author":"Gao","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.vph.2013.07.005_bb0050","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1388-9842(01)00159-3","article-title":"Torsades de pointes caused by mibefradil","volume":"3","author":"Gl\u00e4ser","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.vph.2013.07.005_bb0055","first-page":"1227","article-title":"Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines","volume":"45","author":"Grissmer","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.vph.2013.07.005_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1113\/jphysiol.1988.sp016916","article-title":"Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells","volume":"395","author":"Hagiwara","year":"1988","journal-title":"J Physiol"},{"key":"10.1016\/j.vph.2013.07.005_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s002320010041","article-title":"Verapamil block of large-conductance Ca-activated K channels in rat aortic myocytes","volume":"179","author":"Harper","year":"2001","journal-title":"J Membr Biol"},{"key":"10.1016\/j.vph.2013.07.005_bb0070","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.bjp.0705281","article-title":"Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4K+ channels expressed in HEK293 cells","volume":"139","author":"Hatano","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2013.07.005_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1126\/science.2447647","article-title":"Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons","volume":"239","author":"Hirning","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.vph.2013.07.005_bb0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1254\/jphs.12104FP","article-title":"The T-type Ca2+ channel inhibitor mibefradil inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells","volume":"120","author":"Hong","year":"2012","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.vph.2013.07.005_bb0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pharmthera.2011.11.006","article-title":"Voltage-gated calcium channels and Parkinson's disease","volume":"133","author":"Hurley","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.vph.2013.07.005_bb0090","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1469-7793.2000.00415.x","article-title":"Intracellular Ca2+ release contributes to automaticity in cat atrial pacemaker cells","volume":"524","author":"H\u00fcser","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.vph.2013.07.005_bb0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pbiomolbio.2009.10.001","article-title":"Pathophysiology of voltage-gated K+ channels in vascular smooth muscle cells: modulation by protein kinases","volume":"103","author":"Ko","year":"2010","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.vph.2013.07.005_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1248\/bpb.33.47","article-title":"Calcium channel inhibitor, verapamil, inhibits the voltage-dependent K+ channels in rabbit coronary smooth muscle cells","volume":"33","author":"Ko","year":"2010","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.vph.2013.07.005_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1440-1681.2002.03651.x","article-title":"Molecular diversity of vascular potassium channel isoforms","volume":"29","author":"Korovkina","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.vph.2013.07.005_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000094900","article-title":"Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms","volume":"78","author":"Lee","year":"2006","journal-title":"Pharmacology"},{"key":"10.1016\/j.vph.2013.07.005_bb0115","doi-asserted-by":"crossref","first-page":"H1160","DOI":"10.1152\/ajpheart.2001.280.3.H1160","article-title":"Influence of permeating ions on Kv1.5 channel block by nifedipine","volume":"280","author":"Lin","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.vph.2013.07.005_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/jpet.107.125245","article-title":"Potent inhibition of native TREK-1K+ channels by selected dihydropyridine Ca2+ channel antagonists","volume":"323","author":"Liu","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.vph.2013.07.005_bb0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/hh1401.093294","article-title":"High glucose impairs voltage-gated K+ channel current in rat small coronary arteries","volume":"89","author":"Liu","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.vph.2013.07.005_bb0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/01.RES.79.2.295","article-title":"Alterations in rat interlobar artery membrane potential and K+ channels in genetic and nongenetic hypertension","volume":"79","author":"Martens","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.vph.2013.07.005_bb0135","first-page":"247","article-title":"Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative","volume":"304","author":"Masuda","year":"1990","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.vph.2013.07.005_bb0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-2999(98)00204-0","article-title":"Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect","volume":"349","author":"Masumiya","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2013.07.005_bb0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1152\/ajpcell.1995.268.4.C799","article-title":"Physiological roles and properties of potassium channels in arterial smooth muscle","volume":"268","author":"Nelson","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.vph.2013.07.005_bb0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003495-200969010-00002","article-title":"Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation","volume":"69","author":"Ohashi","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.vph.2013.07.005_bb0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1254\/jphs.FMJ05002X2","article-title":"Pathophysiological significance of T-type Ca2+ channels: properties and functional roles of T-type Ca2+ channels in cardiac pacemaking","volume":"99","author":"Ono","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.vph.2013.07.005_bb0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbrc.2007.07.057","article-title":"The mitochondrial Ca2+-activated K+ channel activator, NS 1619 inhibits L-type Ca2+ channels in rat ventricular myocytes","volume":"362","author":"Park","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vph.2013.07.005_bb0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.RES.77.3.575","article-title":"Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKV1.5 channel","volume":"77","author":"Snyders","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.vph.2013.07.005_bb0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.ATV.21.1.28","article-title":"Potassium channel function in vascular disease","volume":"21","author":"Sobey","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.vph.2013.07.005_bb0175","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.lfs.2011.06.017","article-title":"The inhibitory effect of Ca2+-activated K+ channel activator, BMS on L-type Ca2+ channels in rat ventricular myocytes","volume":"89","author":"Son","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.vph.2013.07.005_bb0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbrc.2012.05.091","article-title":"The inhibitory effect of BIM (I) on L-type Ca2+ channels in rat ventricular cells","volume":"423","author":"Son","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vph.2013.07.005_bb0185","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-201X.1998.00433.x","article-title":"K+ channel modulation in arterial smooth muscle","volume":"164","author":"Standen","year":"1998","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.vph.2013.07.005_bb0190","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.56.8.1028","article-title":"Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura","volume":"56","author":"Terwindt","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.vph.2013.07.005_bb0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03020488","article-title":"Calcium channels\u2014basic aspects of their structure, function and gene encoding; anesthetic action on the channels\u2014a review","volume":"49","author":"Yamakage","year":"2002","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.vph.2013.07.005_bb0200","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00005344-199710000-00013","article-title":"Multiple modulations of action potential duration by different calcium channel blocking agents in guinea pig ventricular myocytes","volume":"30","author":"Zhang","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.vph.2013.07.005_bb0205","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuroscience.2009.03.012","article-title":"Dihydropyridine block of voltage-dependent K+ currents in rat dorsal root ganglion neurons","volume":"161","author":"Zhang","year":"2009","journal-title":"Neuroscience"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189113000815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189113000815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T22:04:43Z","timestamp":1563487483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189113000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":41,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1537189113000815"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2013.07.005","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Ca2+ channel inhibitor efonidipine decreases voltage-dependent K+ channel activity in rabbit coronary arterial smooth muscle cells","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2013.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}